title: [A case of gastric cancer with a synchronous hepatic metastasis responding to postoperative oral administration of UFT and intermittent intrahepatic arterial chemotherapy of 5-FU].
abstract: A 65-year-old male was admitted to our hospital because of sudden onset of upper abdominal pain due to the perforation of gastric cancer with synchronous hepatic metastasis. He underwent total gastrectomy with lymphatic dissection of D1 + alpha. Pathological diagnosis of the surgical specimen was moderately differentiated tubular adenocarcinoma. The cancer progression was fStage IV (T1, N0, H1, P0). Since 50 days after surgery, he had received oral administration of UFT (300-600 mg/day) and intermittent intrahepatic arterial infusion of 5-FU (one injection, 500 mg/2 weeks). Seven months after the start of chemotherapy, the size of hepatic lesion was reduced. Thirteen months later, the tumor became necrotic with cystic change. Furthermore, 22 months later, abdominal CT scan showed complete response. He has been well without recurrence for 38 months following the start of chemotherapy.
authors.affiliation: Dept. of Surgery, Kosei Central Hospital.
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Saito
authors.forename: Akihiko
authors.initials: A
authors.lastname: Tsuchida
authors.forename: Yasuharu
authors.initials: Y
authors.lastname: Hayashida
authors.forename: Makoto
authors.initials: M
authors.lastname: Takagi
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Tamura
authors.forename: Hideaki
authors.initials: H
authors.lastname: Kawakita
authors.forename: Takeo
authors.initials: T
authors.lastname: Kubouchi
authors.forename: Masao
authors.initials: M
authors.lastname: Kinoshita
authors.forename: Shigeki
authors.initials: S
authors.lastname: Sato
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Kataba
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Aoki
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D000284:Administration, Oral; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005472:Fluorouracil / Q000008:administration & dosage; D005743:Gastrectomy; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008197:Lymph Node Excision; D008297:Male; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; C096910:UFT(R) drug; D005641:Tegafur; D014498:Uracil; D005472:Fluorouracil